Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
The Market Herald's July 2021 interview with Iggy Tan covers topics including YouTube Kids and the financial challenges of Canada Post.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tommy Logtenberg is the CEO of The Market Herald.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Peter Thiel: The Future Lies in Bold Innovation, Not Incremental Progress
00:10:00
Exploring the Impact of Digital Transformation on Commercial Real Estate Financing | Patrick Turner, Managing Director, Veronis Suhler Stevenson Capital Partner.
00:10:00
Greg Brown, CEO of hipages Group Holdings Pty Ltd, speaks at the ASX Small and Mid-Cap Conference in March 2024.
00:10:00
Insights into Lindsell Train's Global Equity Fund with Michael Lintzel: Philosophy, Strategy, and Performance | Michael Lindsell , Co-founder , Lindsell Train.
00:10:00
Gulf Countries, Led by UAE, Explore Trade and Investment Opportunities in Africa
00:10:00
Dubai's Retail Boom: A Key Opportunity for Global Brands
00:10:00
Howard Marks on Debt Investing and the End of Low-Interest Regimes: Insights from Oaktree Capital's Co-Founder and Co-Chairman
00:10:00
Investing in Emerging Markets: Insights from James Donald of Lazard | James Donald - Fund Manager, Lazard Emerging Markets Fund
00:10:00
BehindTheBell: A conversation with Joseph M. Harary, President and CEO of Research Frontiers, and Gauzy CEO Eyal Peso, discussing industry insights and collaborations.
00:10:00
ATEX Resources' Valeriano Project Update
00:10:00
Ricardo Mussa on the Rapid Growth of ESG in Brazil | Ricardo Mussa, CEO , Raízen SA.
00:10:00
Stefan Poz on Moonfare's Mission and the Impact of ELTIF 2.0